{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05699213",
            "orgStudyIdInfo": {
                "id": "STUDY00002249"
            },
            "organization": {
                "fullName": "Cedars-Sinai Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening",
            "officialTitle": "A Pilot Study Evaluating the Feasibility of Novel MRI Sequences and Blood-Based Biomarkers for Discriminating Nodules Found During Lung Cancer Screening",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "mri-and-biomarkers-for-lung-nodules-detected-during-lung-cancer-screening"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06-27",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08-27",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-09",
            "studyFirstSubmitQcDate": "2023-01-22",
            "studyFirstPostDateStruct": {
                "date": "2023-01-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-28",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Sara Ghandehari",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "Cedars-Sinai Medical Center"
            },
            "leadSponsor": {
                "name": "Cedars-Sinai Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research for lung cancer screening."
        },
        "conditionsModule": {
            "conditions": [
                "Lung Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Lung MRI",
                    "description": "MRI of the lung"
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Blood Draw",
                    "description": "Blood Draw"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Accrual and Retention Rate",
                    "description": "The primary outcome measure is the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research.",
                    "timeFrame": "3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Concordance of Size of Nodules",
                    "description": "The secondary objective of this study is to evaluate the concordance of imaging features of nodules on LDCT versus MRI in a screening population. Concordance of the size of nodules on LDCT versus MRI will be analyzed using Bland Altman and linear regression.",
                    "timeFrame": "3 Years"
                },
                {
                    "measure": "Concordance of Nodule Features: Presence of Calcifications",
                    "description": "The secondary objective of this study is to evaluate the concordance of imaging features of nodules on LDCT versus MRI in a screening population. Concordance for the presence of calcifications will be analyzed using McNemar's test, sensitivity and specificity.",
                    "timeFrame": "3 years"
                },
                {
                    "measure": "Concordance of Nodule Features: Presence of Fat",
                    "description": "The secondary objective of this study is to evaluate the concordance of imaging features of nodules on LDCT versus MRI in a screening population. Concordance for the presence of fat will be analyzed using McNemar's test, sensitivity and specificity.",
                    "timeFrame": "3 years"
                },
                {
                    "measure": "Concordance of Nodule Features: Presence of Spiculations",
                    "description": "The secondary objective of this study is to evaluate the concordance of imaging features of nodules on LDCT versus MRI in a screening population. Concordance for the presence of spiculations will be analyzed using McNemar's test, sensitivity and specificity.",
                    "timeFrame": "3 years"
                },
                {
                    "measure": "Concordance of Nodule Features: Solid, Part Solid, Non-Solid",
                    "description": "The secondary objective of this study is to evaluate the concordance of imaging features of nodules on LDCT versus MRI in a screening population. Concordance for whether the nodule is solid, part solid, or non-solid will be analyzed using McNemar's test, sensitivity and specificity.",
                    "timeFrame": "3 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Exploratory Outcomes",
                    "description": "The exploratory objectives of this study are to generate preliminary data in support of larger studies in a lung cancer screening population looking at: 1) the use of genetic biomarkers and 2) the use of novel MRI acquisition parameters and radiomics",
                    "timeFrame": "3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability to read and understand informed consent\n* Male or female adults who are at high risk for lung cancer and are enrolled in the centralized lung cancer screening program: Based on USPSTF guidelines: Age 50-80 with 20 or greater pack-year smoking story who continue to smoke or quit within the past 15 years without sign or symptoms of lung cancer. Or based on National Comprehensive Cancer Network (NCCN) guidelines but do not meet the USPSTF guidelines, age 50-unlimited\n* Found to have one or more lung nodules that is 6mm or greater on screening LDCT\n\nExclusion Criteria:\n\n* Persons with an active diagnosis of cancer\n* Persons with active signs or symptoms of lung cancer\n* Persons with mechanically, magnetically, or electrically activated implants, such as cardiac pacemakers, neurostimulators, and infusion pumps.\n* Persons with ferromagnetic implants and ferromagnetic foreign bodies, such as intracranial aneurysm clips, shrapnel and intraocular metal chips as these could become dislodged.\n* Persons who are pregnant, nursing, are implanted with intrauterine devices (IUD's) that are not MR-compatible\n* Persons unable to tolerate MRI imaging secondary to an inability to lie supine or severe claustrophobia.\n* Persons who are non-compliant with visit instructions, including inability to lie still, hold breath or follow procedure instructions",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The primary subject population will be patients who qualify for lung cancer screening based on United States Preventive Services Taskforce (USPSTF) guidelines: Age 50-80 with 20 or greater pack-year smoking history who continue to smoke or have quit within the past 15 years without sign or symptoms of lung cancer.\n\nThe secondary subject population will be patients who are at increased risk of lung cancer based on National Comprehensive Cancer Network (NCCN) guidelines, but do not meet the USPSTF guidelines",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Weijia Chua, MD",
                    "role": "CONTACT",
                    "phone": "310-423-1838",
                    "email": "weijia.chua@cshs.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sara Ghandehari, MD",
                    "affiliation": "Cedars-Sinai",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cedars-Sinai Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Weijia Chua, M.D.",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}